Maternal mid-pregnancy leptin and adiponectin levels as predictors of autism spectrum disorder: A prenatal cohort study
Journal of Clinical Endocrinology and Metabolism Jun 04, 2021
Joung KE, Rifas-Shiman SL, Oken E, et al. - Researchers conducted the study for analyzing the correlations of maternal 2 nd trimester and cord blood leptin and adiponectin levels with autism spectrum disorders (ASD) in offspring. Data were used from 1,164 mother-child pairs enrolled in Project Viva, a prospective pre-birth cohort. Data reported that the cumulative incidence of ASD was 3.4%. Maternal pre-pregnancy BMI (per 5 kg/m 2) was positively linked to ASD in a logistic regression model adjusted for maternal race/ethnicity, education, smoking status, and child sex. ASD was not associated with maternal leptin, cord blood leptin, or adiponectin levels. Pre-pregnancy BMI and adiponectin during pregnancy may be useful in monitoring the risk of autism. Prenatally increasing adiponectin levels may aid in the prevention of ASD.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries